These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37709150)

  • 1. Breast cancer organoids derived from patients: A platform for tailored drug screening.
    Tzeng YT; Hsiao JH; Tseng LM; Hou MF; Li CJ
    Biochem Pharmacol; 2023 Nov; 217():115803. PubMed ID: 37709150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exploration of organoid in breast cancer related research].
    Zheng X; Li J; Sheng J; Zhuo Q; Du Q; Xu Y
    Sheng Wu Gong Cheng Xue Bao; 2021 Feb; 37(2):395-403. PubMed ID: 33645143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer organoids and their applications for precision cancer immunotherapy.
    Guan D; Liu X; Shi Q; He B; Zheng C; Meng X
    World J Surg Oncol; 2023 Oct; 21(1):343. PubMed ID: 37884976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application and prospect of organoid technology in breast cancer.
    Huang S; Mei Z; Wan A; Zhao M; Qi X
    Front Immunol; 2024; 15():1413858. PubMed ID: 39253075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of organoids in renal cell carcinoma research.
    Chen Q; Sun X; Li Y; Yang X; Yang X; Xu H; Cai H; Hu J
    BMC Urol; 2024 Jun; 24(1):120. PubMed ID: 38858665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
    Zhou Z; Cong L; Cong X
    Front Oncol; 2021; 11():762184. PubMed ID: 35036354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of advanced tumor organoids with emerging innovative technologies.
    Mao Y; Hu H
    Cancer Lett; 2024 Aug; 598():217122. PubMed ID: 39029781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
    Cao J; Chan WC; Chow MSS
    Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids.
    Dekkers JF; van Vliet EJ; Sachs N; Rosenbluth JM; Kopper O; Rebel HG; Wehrens EJ; Piani C; Visvader JE; Verissimo CS; Boj SF; Brugge JS; Clevers H; Rios AC
    Nat Protoc; 2021 Apr; 16(4):1936-1965. PubMed ID: 33692550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer Organoids for Tumor Modeling and Drug Screening.
    Yehya A; Ghamlouche F; Hachem S; Abou-Kheir W
    Methods Mol Biol; 2024; 2777():135-144. PubMed ID: 38478341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients.
    Jeong SR; Kang M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
    Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
    In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application.
    Song T; Kong B; Liu R; Luo Y; Wang Y; Zhao Y
    Adv Healthc Mater; 2024 Jan; 13(1):e2300984. PubMed ID: 37694339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of organoid culture in cancer research.
    Zhou C; Wu Y; Wang Z; Liu Y; Yu J; Wang W; Chen S; Wu W; Wang J; Qian G; He A
    Cancer Med; 2023 Jul; 12(13):14375-14386. PubMed ID: 37081739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
    Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
    OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Status of Breast Organoid Models.
    Mohan SC; Lee TY; Giuliano AE; Cui X
    Front Bioeng Biotechnol; 2021; 9():745943. PubMed ID: 34805107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.